Novolog Pharm (Israel) Analysis
NVLG Stock | 169.70 0.70 0.41% |
Novolog Pharm Up 1966 is overvalued with Real Value of 136.66 and Hype Value of 169.7. The main objective of Novolog Pharm stock analysis is to determine its intrinsic value, which is an estimate of what Novolog Pharm Up 1966 is worth, separate from its market price. There are two main types of Novolog Pharm's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Novolog Pharm's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Novolog Pharm's stock to identify patterns and trends that may indicate its future price movements.
The Novolog Pharm stock is traded in Israel on Tel Aviv Stock Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Sun except for officially observed holidays in Israel. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Novolog Pharm's ongoing operational relationships across important fundamental and technical indicators.
Novolog |
Novolog Stock Analysis Notes
About 42.0% of the company outstanding shares are owned by corporate insiders. The book value of Novolog Pharm was now reported as 0.86. The company last dividend was issued on the 24th of November 2022. Novolog Ltd operates as a health logistics company in Israel. Novolog Ltd operates as a subsidiary of Pharm-Up Ltd. Novolog Ltd operates under Medical Care classification in Israel and is traded on Tel Aviv Stock Exchange. To find out more about Novolog Pharm Up 1966 contact Rafi Friedman at 972 8 660 4400 or learn more at https://www.novolog.co.il.Novolog Pharm Up Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Novolog Pharm's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Novolog Pharm Up 1966 or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Novolog Pharm Up 1966 has accumulated 916 K in total debt with debt to equity ratio (D/E) of 0.6, which is about average as compared to similar companies. Novolog Pharm Up has a current ratio of 0.94, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Novolog Pharm until it has trouble settling it off, either with new capital or with free cash flow. So, Novolog Pharm's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Novolog Pharm Up sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Novolog to invest in growth at high rates of return. When we think about Novolog Pharm's use of debt, we should always consider it together with cash and equity. | |
About 42.0% of Novolog Pharm outstanding shares are owned by corporate insiders |
Novolog Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.09 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Novolog Pharm's market, we take the total number of its shares issued and multiply it by Novolog Pharm's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Novolog Profitablity
Novolog Pharm's profitability indicators refer to fundamental financial ratios that showcase Novolog Pharm's ability to generate income relative to its revenue or operating costs. If, let's say, Novolog Pharm is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Novolog Pharm's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Novolog Pharm's profitability requires more research than a typical breakdown of Novolog Pharm's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.03 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05. Technical Drivers
As of the 11th of December 2024, Novolog Pharm secures the Mean Deviation of 1.43, downside deviation of 1.51, and Risk Adjusted Performance of 0.1436. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novolog Pharm Up, as well as the relationship between them.Novolog Pharm Up Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Novolog Pharm middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Novolog Pharm Up. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Novolog Pharm Outstanding Bonds
Novolog Pharm issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Novolog Pharm Up uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Novolog bonds can be classified according to their maturity, which is the date when Novolog Pharm Up 1966 has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
MPLX LP 4875 Corp BondUS55336VAG59 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Novolog Pharm Predictive Daily Indicators
Novolog Pharm intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Novolog Pharm stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Novolog Pharm Forecast Models
Novolog Pharm's time-series forecasting models are one of many Novolog Pharm's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Novolog Pharm's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Novolog Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Novolog Pharm prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Novolog shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Novolog Pharm. By using and applying Novolog Stock analysis, traders can create a robust methodology for identifying Novolog entry and exit points for their positions.
Novolog Ltd operates as a health logistics company in Israel. Novolog Ltd operates as a subsidiary of Pharm-Up Ltd. Novolog Ltd operates under Medical Care classification in Israel and is traded on Tel Aviv Stock Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Novolog Pharm to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
All Next | Launch Module |
Complementary Tools for Novolog Stock analysis
When running Novolog Pharm's price analysis, check to measure Novolog Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novolog Pharm is operating at the current time. Most of Novolog Pharm's value examination focuses on studying past and present price action to predict the probability of Novolog Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novolog Pharm's price. Additionally, you may evaluate how the addition of Novolog Pharm to your portfolios can decrease your overall portfolio volatility.
Commodity Directory Find actively traded commodities issued by global exchanges | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |